EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 7 December 2023

Enhancing health data and patients' care

Stakeholder coalition calls for legislative refinement of the EHDS
04 December 2023

Recommendations to facilitate the resolution of five key challenges that will define the impact of the EHDS and its... Read more

EFPIA response to EHDS to the text adopted by ENVI/LIBE committee in the European Parliament...
01 December 2023

Sharing a range of electronic health data types for secondary purposes through the EHDS can boost research and innovation,... Read more

Innovative industry joint statement on Climate and Health

Innovative pharmaceutical industry statement on COP28 Declaration on Climate and Health
03 December 2023

By IFPMA, ABPI, EFPIA, Farmindustria, Innovative Medicines Canada, JPMA, Leem, PhRMA, vfa Read more

Vaccines Europe pipeline review 2023

Vaccine innovation & vaccination play a key role in public health. The newly released 2023 Pipeline Review showcases vaccine manufacturers' commitment to:

Reduce preventable health threats
Save millions of lives woldwide
Contribute to health & socio-economic resilience

IMI impact on vaccines

How do IMI projects facilitate innovations in vaccine development and improve their assessment?

Watch the webinar recording.

What we are reading

You are invited to the “Vote Cardiovascular Health 2024” exhibition
On 06 December 2023 (EACH)

It will take place at the European Parliament in Strasbourg, Swan Bar (Bar des cygnes) area, from December 11th to... Read more

The future for Europe and the role of medical innovation
On 01 December 2023 (LinkedIn)

Read Phil Southerland, CEO & Founder at Supersapiens and patient advocate, reaction to Lars Fruergaard Jørgensen... Read more

EU Pharma Wants Regulators’ Help To Simplify Digital Endpoints Landscape
On 30 November 2023 (Pink Sheet)

EFPIA says its member companies are not looking for shortcuts to develop and validate digital biomarkers, but want... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu